Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1994-10-24
1999-02-09
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
4241841, 4241851, 424458, 424463, 424464, 424474, 424489, 514 2, 514 21, 514825, A61K 948, A61K 3702
Patent
active
058690930
ABSTRACT:
The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease. The method of the invention includes both prophylactic and therapeutic measures.
REFERENCES:
patent: 4804745 (1989-02-01), Koepff et al.
patent: 5075112 (1991-12-01), Lane
patent: 5399347 (1995-03-01), Trentham et al.
Wells, H., J. Infect. Dis. 9:147 (1911).
Ngan, J. et al., J. Immunol. 120:861 (1978).
Gautam, S. C. et al., J. Immunol. 135:2975 (1985).
Titus, R. et al., Int. Arch. Allergy Appl. Immunol. 65:323 (1981).
Higgins, P. J. et al., J. Immunol. 140:440 (1988).
Lider, O. et al., J. Immunol. 142:748 (1989).
Bitar, D. M. et al., Cell. Immunol. 112:364 (1988).
Nagler-Anderson, C. et al., Proc. Natl. Acad. Sci. USA 83:7443 (1986).
Thompson, H. S. G. et al., Clin. Exp. Immunol. 64:581 (1985).
Swierkosz, J. E. et al., J. Immunol. 119:1501 (1977).
Lando, Z. et al., Nature 287:551 (1980).
Lando, Z. et al., J. Immunol. 126:1526 (1981).
Sriram, S. et al., Cell. Immunol. 75:378 (1983).
Alvord, E. C. et al., Annals of Neurol. 6:461 (1979).
Alvord, E. C. et al., Annals of Neurol. 6:469 (1979).
Alvord, E. C. et al., Annals of Neurol. 6:474 (1979).
Traugott, U. et al., J. Neurol. Sci. 56:65 (1982).
Raine, C. S. et al., Lab. Invest. 48:275 (1983).
McKenna, R. et al., Cell. Immunol. 81:391 (1983).
Strejan, G. et al., Cell. Immunol. 84:171 (1984).
McKenna, R. et al., Cell. Immunol. 88:251 (1984).
Burns, J. et al., Neurology 36:92 (1986).
Belik, Y. et al., Vopr. Med. Khim. 24:372 (1978).
Mowat, A. M., Immunol. Today 8:93 (1987).
Trentham, D. E. et al., J. Clin. Invest. 66:1109 (1980).
Myers, L. K. et al., J. Exp. Med. 170:1999 (1989).
Myers, L. K. et al., J. Immunol. 143:3976 (1989).
Kardys, E. et al., J. Immunol. 127:862 (1981).
Holoshitz, J. et al., J. Immunol. 131:2810 (1983).
Mokhtarian, F. et al., Nature 309:356 (1984).
Braley-Mullen, H. et al., Cell. Immun. 39:289 (1978).
McDermott, J. R. et al., J. Neurol. Sci. 46:137 (1980).
Raziuddin, S. et al., J. Immunol. 128:2073 (1982).
Alvord, E. C. et al., Ann. N.Y. Acad. Sci. 122:333 (1965).
Higgins, P. J. et al., J. Neuroimmunol. 16:77 (1987).
Higgins, P. J. et al., Annals of Neurol. 20:161, Abstract P154 (1986).
Whitacre, C. C. et al., Abstr. 6th Int'l. Congr. Immunol., Toronto (Jul. 1986) (Distrib. to Registered Attendees Upon Request, May 1986).
Whitacre, C. C. et al., Titles of Workshop Presentations No. 615-09, 5th Int'l. Congr. of Immunol. Kyoto, Japan (1983).
Schoen, R. T. et al., J. Immunol. 128:717 (1982).
Eylar, E. H., Adv. Exp. Med. Biol. 98:259 (1978).
Gonsette, R. E. et al., J. Neurol. 216:27 (1977).
Campbell, B. et al., Arch. Neurol. 29:10 (1973).
Zhang et al., FASEB J. 4:A2258, Abstract No. 3264 (1990).
Whitaker, J. N. et al., J. Biol. Chem. 250:9106-9111 (1975).
Allegreta, M., et al., Science 247:718, 1990.
Cremer, et al., J. Immunol. 87:2995, 1983.
Englert, et al., Cell. Immunol. 87:357, 1984.
Janeway, Nature 341:482-83, 1989.
Lane, I. William et al., Sharks Don't Get Cancer, Avery Publishing Group Inc., 1992, updated edition 1993.
Miller, A., et al., J. Exp. Med. 174:791, 1991.
Miller, A., et al., Proc. Natl. Acad. Sci. USA 89:421, 1992.
Pinals, R. S., et al., Arthritis Rheum. 24:1308, 1981.
Rama, et al., Connective Tissue Research 12:111, 1984.
Santos, L. M. B., et al., J. Immunol. 150:115A, 1993.
Sewel, K.L. and Trentham, D.E., The Lancet 341:283, 1993.
Steinbrocker, O., et al., JAMA 140:659, 1949.
Trentham, D. E., et al., Science 261:1727, 1993.
Weinblatt, M.E., et al., N. Eng. J. Med. 312:818, 1985.
Weiner, H. L., et al., Science 259:1321, 1993.
Whitacre, C. C., et al., J. Immunol. 147:2155, 1991.
Williams, H. J. et al., Arthritis Rheum. 31:702, 1988.
Zhang, Z. J., et al., J. Immunol. 145:2489, 1990.
Unanue et al., Science, 236:551-557 (1987).
Mattingly et al., Jour. of Immunol., 125:1044-1047 (1980).
Holoshitz et al., Science, 219:56-58 (1983).
Whitaker, Jour. of Biol. Chem., 250:9106-9111.
Miller, FASEB, 5:2560-2566 (1991).
Phadke et al., Arthritis and Rheumatism, 27(7):797-806 (1984).
Braley-Mullen et al., Cellular Immunology, 5:408-413 (1980).
Salk et al., Studies of Myelin Basic Protein Administration in Multiple Sclerosis Patients, 419-427 (1984).
Eylar et al., Nature, 236:74 (1972).
Michael, Immunol. Invest., 18:1049-1054 (1989).
Higgins et al., J. Immunology, 140:440-445, 1988.
Eylar, Adv. Exp. Med. Bio., 98:259-281, 1978.
Sriram et al., Cell. Immunol., 75:378-382, 1983.
Nagler-Anderson et al., PNAS, 83:7443-7446, 1986.
Schoen, J. Immunol., 128:717-719, 1982.
Higgins et al., Annals Neurology, abstract No. P154, 1986.
Whitacre et al., 6th Int'l. Cong. Immunol., abstract No. 3.62.21, 1986.
Zamvil et al., Nature, 324:258-260, 1986.
Fritz et al., J. Immunol., 134:2328-2332, 1985.
Fritz et al., J. Immunol., 130:191-194, 1983.
Pettinelli et al., J. Immunol., 129:1209-1211, 1982.
Whitaker et al., J. Bio. Chem, 250:9106-9111, 1975.
Thompson et al., Clin. Exp. Immunol., 64:581-586, 1985.
Lider et al., J. Immunol., 142:748-752, 1989.
Friedman et al., PNAS, 91:6688-6692, 1994.
Bitar, dissertation entitled, The Suppressive Effects of Oral Myelin Basic Protein . . . , 1986.
Nagler-Anderson, dissertation entitled, Immunoregulation of an Exp. Model of Autoimmunity, 1986.
Rothbart, 1st Forum in Virology, pp. 518-520, 1986.
Bitar et al., Cell. Immunol., 112:364-370, 1988.
Eylar et al., Neurochem. Research, 4:249-258, 1979.
Kagnoff, Oral Tolerance, pp. 248-269, 1982.
Mowat, Immunol. Today, 8:93-98, 1987.
Weiner et al., Science, 259:1321-1324, 1993.
Campbell et al, Arch. Neurol., 29:10-15, 1973.
Carnegie et al.,Immunol. 19:55-63, 1970.
Fritz et al., J. Immunol., 130:1024-1026, 1983.
Hashim et al., Arch. Biochem. and Biophy., 156:287-297, 1973.
AutoImmune Press Release of Apr. 21, 1997.
AutoImmune Press Release of May 12, 1997.
Higgins et al, J. Immunol. vol. 140, No. 2, pp. 440-445, Jan. 15, 1988.
Higgins et al, J. Neuroimmunol. vol. 16, No. 1, p. 77, Sep. 1987.
Lider et al, J. Immunol. vol. 142, No. 3, pp. 748-752, Feb. 1, 1989.
Bitar et al, Cellular Immunol., vol. 112, pp. 364-370, 1988.
Whitacre et al, Abstract, 6th. Int'l Cong. Immunol., Toronto (Jul. 1986). Ref. No. 3-62-21.
Zhoug et al, FASEB J. 4:A2258, Abstract No. 3264.
Nagler-Anderson et al, Proc. Nat. Acad. Sci. USA, vol. 83, pp. 7443-7446, Oct. 1986.
Thompson et al, Clin. Exp. Immunol. vol. 64, pp. 581-586, 1985.
Hafler David A.
Weiner Howard L.
Achutamurthy Ponnathapura
Autoimmune Inc.
LandOfFree
Treatment of immune diseases by oral administration of autoantig does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of immune diseases by oral administration of autoantig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immune diseases by oral administration of autoantig will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1946863